These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26573790)

  • 1. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
    Koo J; Dhall D
    Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.
    Bellizzi AM
    Adv Anat Pathol; 2013 Sep; 20(5):285-314. PubMed ID: 23939147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine neoplasms of the lung: Concepts and terminology.
    Wick MR; Marchevsky AM
    Semin Diagn Pathol; 2015 Nov; 32(6):445-55. PubMed ID: 26500079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
    Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic difficulties with the diagnosis of small cell carcinoma of the lung.
    Marchevsky AM; Wick MR
    Semin Diagn Pathol; 2015 Nov; 32(6):480-8. PubMed ID: 26597580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs.
    Cloutier J; Thompson ED; Cimino-Mathews A; Rooper LM; Matoso A; Argani P
    Hum Pathol; 2018 Dec; 82():76-86. PubMed ID: 30031098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.
    Yang K; Cheng YS; Yang JJ; Jiang X; Guo JX
    World J Gastroenterol; 2015 Mar; 21(10):3132-8. PubMed ID: 25780316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
    Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
    Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Spectrum of Primary and Metastatic Neuroendocrine Neoplasms.
    Hashmi AA; Ali J; Khan K; Ahmed O; Rehman AU; Irfan M; Haroon S; Asif MG
    Cureus; 2020 Nov; 12(11):e11764. PubMed ID: 33409012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
    Saller JJ; Haider M; Al-Diffalha S; Coppola D
    Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
    Scoazec JY
    Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
    Uccella S; La Rosa S; Volante M; Papotti M
    Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
    Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
    Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
    Uccella S; Sessa F; La Rosa S
    Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor: a case report with review of the literature.
    Fiori S; Del Gobbo A; Gaudioso G; Caccamo L; Massironi S; Cavalcoli F; Bosari S; Ferrero S
    Diagn Pathol; 2013 Sep; 8():148. PubMed ID: 24034980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.